Ponatinib for the treatment of adult patients with resistant or intolerant Chronic-Phase Chronic Myeloid Leukemia

Fadi G. Haddad, Ghayas C. Issa, Elias Jabbour, Musa Yilmaz

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Ponatinib for the treatment of adult patients with resistant or intolerant Chronic-Phase Chronic Myeloid Leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences